We are live on ! Find out more
APYX icon

Apyx Medical
APYX

20 hedge funds and large institutions have $4.7M invested in Apyx Medical in 2014 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 8 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

3% more capital invested

Capital invested by funds: $4.56M → $4.7M (+$132K)

13% less funds holding

Funds holding: 23 → 20 (-3)

63% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 8

75% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 4

Holders
20
Holders Change
-3
Holders Change %
-13.04%
% of All Funds
0.58%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
3
Reduced
8
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$4.17K
2
Morgan Stanley
Morgan Stanley
New York
+$2.44K
3
Northern Trust
Northern Trust
Illinois
+$235
4
BIM
BlackRock Investment Management
Delaware
+$77

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$173K
2
VKH
Virtu KCG Holdings
New York
-$59K
3
MIAN
Mariner Independent Advisor Network
Kansas
-$33.5K
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$16.2K
5
TDC
Thompson Davis & Co
Virginia
-$15K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.52M +$4.17K +1,028 +0.3%
Dimensional Fund Advisors
2
Dimensional Fund Advisors
Texas
$1.44M -$4.87K -1,200 -0.3%
Millennium Management
3
Millennium Management
New York
$688K -$173K -42,500 -20%
MIAN
4
Mariner Independent Advisor Network
Kansas
$253K -$33.5K -8,250 -12%
BFA
5
BlackRock Fund Advisors
California
$187K -$13.9K -3,417 -7%
Northern Trust
6
Northern Trust
Illinois
$137K +$235 +58 +0.2%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$118K – – –
California Public Employees Retirement System
8
California Public Employees Retirement System
California
$112K – – –
Royal Bank of Canada
9
Royal Bank of Canada
Ontario, Canada
$64K -$16.2K -4,000 -20%
BIT
10
BlackRock Institutional Trust
California
$63K – – –
First Manhattan
11
First Manhattan
New York
$55K – – –
BA
12
BlackRock Advisors
Delaware
$24K – – –
U
13
UBS
Switzerland
$12K – – –
BIM
14
BlackRock Investment Management
Delaware
$12K +$77 +19 +0.7%
Morgan Stanley
15
Morgan Stanley
New York
$2K +$2.44K +600 New
GC
16
Globeflex Capital
California
$1K -$325 -80 -22%
BNP Paribas Financial Markets
17
BNP Paribas Financial Markets
France
$8 -$97 -24 -92%
VKH
18
Virtu KCG Holdings
New York
– -$59K -16,188 Closed
TDC
19
Thompson Davis & Co
Virginia
– -$15K -4,000 Closed
GSC
20
Ground Swell Capital
South Carolina
– -$4K -1,116 Closed
Manulife (Manufacturers Life Insurance)
21
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$1K -370 Closed
Bank of America
22
Bank of America
North Carolina
– -$1.35K -333 -77%

APYX Hedge Fund Activity: Q3 2014 in Review

20 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Apyx Medical (APYX) for Q3 2014, worth a combined $4.7M — up 2.9% from $4.56M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of APYX and 1 opened new positions — a net loss of 3 holders — while 8 trimmed existing stakes and 3 added.

The largest buyer was Vanguard Group, adding an estimated $4.17K. The largest seller was Millennium Management, cutting an estimated $173K.

  • 20 institutional investors held Apyx Medical (APYX) as of Q3 2014, down from 23 in Q2 2014.
  • Funds reported $4.7M of Apyx Medical stock for Q3 2014, up 2.9% quarter-over-quarter.
  • 1 fund opened new Apyx Medical positions in Q3 2014 and 4 closed out, a net change of -3 holders.
  • The largest Apyx Medical buyer in Q3 2014 was Vanguard Group, an estimated $4.17K added.
  • The largest Apyx Medical seller in Q3 2014 was Millennium Management, an estimated $173K sold.

Based on aggregated 13F filings for Q3 2014.